Page 1385 - Problem-Based Feline Medicine
P. 1385

20 – THE CAT WITH ENLARGED LYMPH NODES  13771377
                                                                                         DRUG INDEX


                    24 on alternate weeks  24  24 24 on alternate weeks  24  24  if 48; reduce to 1/wk  response  7 D  24 ×  24  12–24  12  18 days of age  at  12  12  24  8–12  12  12  Continued
















                    IM, SC,PO  PO  PO  PO  IM  PO  SC  PO, SC, IM  PO  PO  PO  PO  IM  IM  PO  PO  PO  PO  IM, SC
















                    15–30 U/cat  0.5–5.0 U/kg  1 U/cat  30 U/cat  20000 U/cat  10 U/cat  1 million U/kg  15–30 units/cat  50–100 mg/cat  20 mg/kg  0.25 ml/kg  2–6 ml/cat  15 mg/kg  term)  50 mg/cat  Induction: 5% Maintenance: 1.5–2.5%  0.25–0.50 ml/cat  0.5 tablet/cat  10–20 mg/kg  0.2–0.4 mg/kg  block  0.2–1.0 mg/kg  0.5–0.8 mg/kg










                  Non-neoplastic FeLV-  associated disease  appetite stimulation  FeLV  FIP (nonexudative)  FIP (exudative)  herpes  Ocular omega Immunostimulation (FIP)  Immunostimulation  Hyperthyroidism Hyperthroidism, Sporotrichosis  Myelography  Emetic  Hyperthyroidism (short  Anemia  Anesthesia  Urethical antispasmodic  Tuberculosis  Sinus bradycardia, SA or AV  Antidiarrheal












                  (human                2b  α  Iodide sodium, potassium


                  Interferon-α 2  recombinant)  Interferon, feline   recombinant  Interferon, human   recombinant  Iodine  20% solution  Iopamidol  Ipecac syrup  Ipodate  Iron dextran  Isoflurane  Isometheptene  Isoniazid  Isopropamide iodide  Isopropamide/prochlor  perazine
   1380   1381   1382   1383   1384   1385   1386   1387   1388   1389   1390